跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Levophed SF (Sulfite-Free) - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Levophed SF (Sulfite-Free)
Approved
STANDARD
Levophed SF (Sulfite-Free)
Avara Liscate Pharmaceutical
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e74b634fb409f9a8
Company
Avara Liscate Pharmaceutical
Type
Standard
Approval Details
Approval Id
e74b634fb409f9a8
Drug Approval Philippines Name
Levophed SF (Sulfite-Free)
Product Name
Levophed SF (Sulfite-Free)
Registration Number
DR-XY38195
Brand Name
Levophed SF (Sulfite-Free)
Generic Name
Norepinephrine (as bitartrate)
Dosage Form
Concentrate Solution For IV Infusion
Dosage Strength
1mg/mL
Manufacturer
Avara Liscate Pharmaceutical
Importer
Pfizer, Inc.
Distributor
Pfizer, Inc.
Company Detail Path
/organization/avara-liscate-pharmaceutical-services-spa
Importer Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Distributor Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Issuance Date
08 May 2025
Expiry Date
07 July 2037
Pharmacologic Category
Adrenergic Agent and Dopaminergic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e74b634fb409f9a8
Type
Standard
Back to Philippines FDA Approvals